Michael Anderson | CEO |
Mike Kanan | SVP and CFO |
Greg Divis | EVP and CFO |
Lauren Stival | Sr. Director, IR & Corporate Communications |
Matt Kaplan | Ladenburg Thalmann |
Roy Buchanan | JMP Securities |
François Brisebois | Laidlaw & Company |
Scott Henry | Roth Capital Partners |
Good day ladies and gentlemen, and welcome to the Avadel Pharmaceuticals Third Quarter 2017 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Lauren Stival, Director of Investor Relations. Ma'am, you may begin.
Good morning.